Canamera Energy Metals Corp. tests third ionic clay REE asset as Brazil strategy deepens (OTCQB: EMETF)
Can RSA’s Microsoft partnership protect enterprise AI agents from the identity threats no one saw coming?
Arm Holdings launches first in-house data center CPU in historic company pivot targeting agentic AI infrastructure
Barrel Energy Inc. targets environmental infrastructure growth through Happy Traps acquisition in Maine (OTC: BRLL)
Read More 8 minute read Pharma Industry News Amplia Therapeutics (ASX:ATX) reports five complete responses and improved survival in ACCENT pancreatic cancer trial Amplia Therapeutics (ASX:ATX) posts 7.8% complete response rate and 11.1-month mOS in ACCENT pancreatic cancer trial. Read the full strategic analysis. byVenkateshMarch 23, 2026